IPRT Trademark

Trademark Overview


On Thursday, March 24, 2022, a trademark application was filed for IPRT with the United States Patent and Trademark Office. The USPTO has given the IPRT trademark a serial number of 97327943. The federal status of this trademark filing is THIRD EXTENSION - GRANTED as of Wednesday, September 25, 2024. This trademark is owned by ImmunityBio, Inc.. The IPRT trademark is filed in the Pharmaceutical Products, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:

Cells; cell-derived preparations; medicinal, biological and pharmaceutical preparations; products comprising cells; products comprising cell-derived preparations; products comprising biologics; kits comprised of cells, other reagents and instructions; kits comprised of cell-derived preparations, other reagents and instructions for the use thereof; kits comprised of biologics, other reagents and instructions for the use thereof; all of the foregoing for clinical, medical, veterinary and therapeutic use in combination with radiation therapy in the treatment and/or prevention of cancer and infectious diseases

Medical treatment of cancer and infectious diseases using radiation therapy in combination with the administration of cells and cell-derived preparations; medical treatment of cancer and infectious diseases using radiation therapy in combination with the administration of preparations comprising biologics; providing medical information in the fields of cancer and infectious diseases

Research in the field of cancer and infectious diseases; product development in the fields of science, medicine, pharmaceuticals, veterinary medicine, therapeutics and research related thereto for use in combination with radiation therapy
iprt

General Information


Serial Number97327943
Word MarkIPRT
Filing DateThursday, March 24, 2022
Status732 - THIRD EXTENSION - GRANTED
Status DateWednesday, September 25, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 14, 2023

Trademark Statements


Goods and ServicesCells; cell-derived preparations; medicinal, biological and pharmaceutical preparations; products comprising cells; products comprising cell-derived preparations; products comprising biologics; kits comprised of cells, other reagents and instructions; kits comprised of cell-derived preparations, other reagents and instructions for the use thereof; kits comprised of biologics, other reagents and instructions for the use thereof; all of the foregoing for clinical, medical, veterinary and therapeutic use in combination with radiation therapy in the treatment and/or prevention of cancer and infectious diseases
Pseudo MarkIMMUNOGENICITY PRIMING RADIATION THERAPY
Goods and ServicesMedical treatment of cancer and infectious diseases using radiation therapy in combination with the administration of cells and cell-derived preparations; medical treatment of cancer and infectious diseases using radiation therapy in combination with the administration of preparations comprising biologics; providing medical information in the fields of cancer and infectious diseases
Goods and ServicesResearch in the field of cancer and infectious diseases; product development in the fields of science, medicine, pharmaceuticals, veterinary medicine, therapeutics and research related thereto for use in combination with radiation therapy

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, March 29, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, March 29, 2022
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, March 29, 2022
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameImmunityBio, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92121

Party NameImmunityBio, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92121

Trademark Events


Event DateEvent Description
Monday, March 28, 2022NEW APPLICATION ENTERED
Tuesday, March 29, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, January 9, 2023ASSIGNED TO EXAMINER
Tuesday, January 10, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, January 25, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, February 14, 2023PUBLISHED FOR OPPOSITION
Tuesday, February 14, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 11, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, September 7, 2023SOU EXTENSION 1 FILED
Thursday, September 7, 2023SOU TEAS EXTENSION RECEIVED
Thursday, September 7, 2023SOU EXTENSION 1 GRANTED
Wednesday, March 20, 2024SOU TEAS EXTENSION RECEIVED
Wednesday, September 25, 2024SOU TEAS EXTENSION RECEIVED
Wednesday, September 25, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, September 25, 2024SOU EXTENSION 3 FILED
Wednesday, September 25, 2024SOU EXTENSION 3 GRANTED
Thursday, March 21, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Saturday, September 9, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, March 20, 2024SOU EXTENSION 2 FILED
Wednesday, March 20, 2024SOU EXTENSION 2 GRANTED